European equities traded in the US as American depositary receipts fell in Monday trading, declining 0.53% to 1,420.98 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies (DBVT) and Genfit (GNFT), which rose 6.9% and 6.8% respectively. They were followed by biopharmaceutical company Grifols (GRFS) and biotech firm BioNTech (BNTX), which were up 3.4% and 2.8% respectively.
The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and semiconductor company Sequans Communications (SQNS), which dropped 6.6% and 5.2% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and oil and gas company TotalEnergies (TTE), which fell 2.7% and 1.9% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Bicycle Therapeutics (BCYC), which climbed 8.9% and 6% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Verona Pharma (VRNA), which increased 4.5% and 3.6% respectively.
The decliners from the UK and Ireland were led by pharmaceutical company GSK (GSK) and biopharmaceutical company Akari Therapeutics (AKTX), which lost 8.1% each. They were followed by construction materials supplier CRH (CRH) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which were down 3.1% and 1.8% respectively.
Comments